VIAN Therapeutics is an ophthalmology pharma startup combating microvascular retinal diseases (AMD and DME) with a simple eyedrop.
VIAN Therapeutics has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in June 2024.
VIAN Therapeutics's investors include Ulu Ventures, SOSV, SOSV SF & NY (Fka IndieBio), Sand Hill Angels, SeedFolio.
VIAN Therapeutics is headquartered in San Francisco, United States.
VIAN Therapeutics is an ophthalmology pharma startup combating microvascular retinal diseases (AMD and DME) with a simple eyedrop.
VIAN Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VIAN Therapeutics — Funding & Investors." VCBacked, June 25, 2024, https://www.vcbacked.co/company/vian-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). VIAN Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/vian-therapeutics
{{cite web |title=VIAN Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vian-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated